Latest filing published 14 Jul 2023 for Acasti Pharma Inc..
No signal scores available.
Prashant Kohli is a declared insider of Acasti Pharma Inc., with filings sourced from SEDI. In total, 3 filings cover trades dated from 9 September 2022 to 10 July 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 14 July 2023, reports a transaction in Acasti Pharma Inc. The median gap between a trade and its publication by SEDI is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations